investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CRC Tier 1 - Cancer Biology

Linda Penn

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)
Dr. Linda Penns research provides key contributions towards our understanding of cancer biology. Her work has led to the identification of a new cancer target (H19), which is currently in commercial development, and she is exploring the clinical application of a group of drugs known as statins as cancer therapeutics. In addition, with 25 years of experience working on a protein known as Myc which serves as a key player in the development of cancer she has developed unique molecular tools that will allow her to provide key insights that advance the development of more effective, personalized cancer therapies.

Related projects